Market Overview

Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, Forecasts, 2018 - 2025 - ResearchAndMarkets.com

Share:

The "Pharmacokinetics
Services Market Size, Share & Trends Analysis Report By Drug Type (Small
Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive
Landscape, And Segment Forecasts, 2018 - 2025"
report has been
added to ResearchAndMarkets.com's offering.

The global pharmacokinetics services market size is expected to reach
USD 1.2 billion by 2025, registering an 8.3% CAGR during the forecast
period.

Rising adoption of pharmacokinetic and toxicology studies for
determination of several parameters such as no-observed-effect levels
(NOEL), human equivalent doses (HED) levels, and
pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel
market growth.

Thorough understanding of the pharmacokinetic profile of a potential
drug candidate plays a major role in the success of a drug discovery
program. In addition to this, regulatory bodies have played a major role
in the progress of this market through establishing defined guidelines
for conducting PK studies. There are a substantial number of CROs
engaged in conducting PK studies in accordance with relevant EMEA, ICH,
FDA, GCP, and other regulatory guidelines.

Growing concern for effective implementation of PK services in the drug
development process is anticipated to drive investments in this sector.
Several conferences and certification courses are being conducted across
the world to increase the understanding of various paradigms associated
with pharmacokinetics application in clinical and preclinical drug
development.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Pharmacokinetics Services Market Variables, Trends & Scope

Chapter 4 Pharmacokinetics Services Market: Drug Type Estimates & Trend
Analysis

Chapter 5 Pharmacokinetics Services Market: Regional Estimates & Trend
Analysis, by Drug Type

Chapter 6 Competitive Landscape

  • Evotec AG
  • Certara, L.P.
  • Pacific BioLabs
  • GVK Biosciences Private Limited
  • Shanghai Medicilon Inc.
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corporation
  • Eurofins Scientific, Inc.
  • Frontage Labs
  • SGS SA
  • LGC Limited
  • Creative Bioarray

For more information about this report visit https://www.researchandmarkets.com/research/cfx7vk/pharmacokinetics?w=4

View Comments and Join the Discussion!